Wordt geladen...
Mutation EthA(W21R) confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
Ethionamide (ETA) and prothionamide (PRO) are interchangeably used in tuberculosis (TB) chemotherapy regimens. Subtle discrepancies between biochemical and genetic information on the modes of sensitivity and resistance of isoniazid (INH) and ETA warrants further studies. We report a new mutation – E...
Bewaard in:
| Gepubliceerd in: | Infect Drug Resist |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005328/ https://ncbi.nlm.nih.gov/pubmed/29942141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S163965 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|